Jump to Content
Jump to Main Navigation
User Account
Sign In
to save searches and organize your favorite content.
Not registered?
Sign up
My Content
(0)
Recently viewed
(0)
Save Entry
Searches
(0)
Recently viewed
(0)
Save Search
More
Subscriptions
Join E-mail List
Help
JNCCN
Menu
Home
Content
Current Issue
Past Issues
Featured Online Content
Supplements
NCCN Meeting Highlights
JNCCN In the News
NCCN News
Highlights of the NCCN Oncology Research Program
Video Roundtables
COVID-19
CE
JNCCN 360
Author Center
Call for Papers
Submit a Manuscript
Information for Authors
Reprints/Permissions
About
JNCCN
Editorial Board
Editorial Calendar
NCCN
Harborside / BroadcastMed
Search
Close
Advanced Search
Help
Search within results
Search within results
Filter
Filter
Refine by Access
All
Content accessible to Me
Refine by Date
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
—
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
Submit
Print
Save
Email this link
Share Link
Copy this link, or click below to email it to a friend
Email this link
or copy the link directly:
https://jnccn.org/browse?access=all&page=15&pageSize=10&sort=datedescending
The link was not copied. Your current browser may not support copying via this button.
Link copied successfully
Copy link
Browse
You are looking at
141
-
150
of
4,190
items for
Refine by Access: All
x
Clear All
Items per page
10
20
50
Sort by
Article A - Z
Article Z - A
Author A - Z
Author Z - A
Date - Old to Recent
Date - Recent to Old
Page: ...
10
11
12
13
14
15
16
17
18
19
20
...
Full access
HSR23-097: Health-Related Quality of Life in Patients With Metastatic Basal Cell Carcinoma Treated With Cemiplimab: Analysis of a Phase 2 Open-Label Clinical Trial
Karl D. Lewis, Timothy J. Inocencio, Ruben G.W. Quek, Patrick R. LaFontaine, Zeynep Eroglu, Anne Lynn S. Chang, Cristina Ivanescu, Alexander J. Stratigos, Ketty Peris, Aleksandar Sekulic, Matthew G. Fury, and Chieh-I Chen
In
Journal of the National Comprehensive Cancer Network Volume 21 (2023): Issue 3.5 (Mar 2023): Abstracts from the NCCN 2023 Virtual Annual Conference
31 Mar 2023
Full access
HSR23-098: Extensive and Dynamic Signs and Symptoms Prior to Cancer Diagnoses
Ze Cong and Xiangyang Ye
In
Journal of the National Comprehensive Cancer Network Volume 21 (2023): Issue 3.5 (Mar 2023): Abstracts from the NCCN 2023 Virtual Annual Conference
31 Mar 2023
Full access
HSR23-099: Reasons for Lung Cancer Patients to Present to the ED
Kamil Taneja, Steven Chen, Kevin Metz, William Benedict, and Karan Patel
In
Journal of the National Comprehensive Cancer Network Volume 21 (2023): Issue 3.5 (Mar 2023): Abstracts from the NCCN 2023 Virtual Annual Conference
31 Mar 2023
Full access
HSR23-100: The Potential Clinical Impact of a Multi-Cancer Early Detection Test for Individuals With Missing Cancer Stage Information
Ali Tafazzoli, Alissa Shaul, Weicheng Ye, Anuraag R. Kansal, and A. Mark Fendrick
In
Journal of the National Comprehensive Cancer Network Volume 21 (2023): Issue 3.5 (Mar 2023): Abstracts from the NCCN 2023 Virtual Annual Conference
31 Mar 2023
Full access
HSR23-101: Characteristics and Outcomes of Patients Treated With Selpercatinib in the Real-World: A Retrospective Study Using US Claims Databases
Naleen Raj Bhandari, Neha Bansal, Chi-Wei Duann, Anasofia Afonso, and Shen Zheng
In
Journal of the National Comprehensive Cancer Network Volume 21 (2023): Issue 3.5 (Mar 2023): Abstracts from the NCCN 2023 Virtual Annual Conference
31 Mar 2023
Full access
HSR23-102: Diagnosis of Metastatic Non–Small Cell Lung Cancer During Hospitalization: Missed Opportunity for Optimal Supportive Care?
Shristi Upadhyay Banskota, Conor Houlihan, Jonathan Q. Trinh, Samia Asif, Omar Abughanimeh, and Benjamin A. Teply
In
Journal of the National Comprehensive Cancer Network Volume 21 (2023): Issue 3.5 (Mar 2023): Abstracts from the NCCN 2023 Virtual Annual Conference
31 Mar 2023
Full access
HSR23-103: Pancreatic Cancer: The Impact of Early Connectivity and Coordination of Care on Retention and Time to Treat
Nicole Nardella, Matt Adams, Anjali Mahapatra, Diana Castillo, Sarah Hoffe, Dae Won Kim, Jason Fleming, and Pamela Hodul
In
Journal of the National Comprehensive Cancer Network Volume 21 (2023): Issue 3.5 (Mar 2023): Abstracts from the NCCN 2023 Virtual Annual Conference
31 Mar 2023
Full access
HSR23-104: How Pancreatic Patients Choose Their Cancer Center: An Analysis of Factors That Influence Retention
Matt Adams, Nicole Nardella, Anjali Mahapatra, Diana Castillo, Sarah Hoffe, Dae Won Kim, Jason Fleming, and Pamela Hodul
In
Journal of the National Comprehensive Cancer Network Volume 21 (2023): Issue 3.5 (Mar 2023): Abstracts from the NCCN 2023 Virtual Annual Conference
31 Mar 2023
Full access
HSR23-105: Real-World Dosing Patterns in Patients With Anaplastic Lymphoma Kinase Positive (ALK+) Non–Small Cell Lung Cancer (NSCLC) Treated With Brigatinib in the Front-Line (FL) Setting in the United States: A Claims Database Analysis
Edmund W. Tai, Huamao Mark Lin, Yanyu Wu, Yin Wan, Magdaliz Gorritz, Xiaoyu Zhou, Chi-Chang Chen, and Yuanbin Chen
In
Journal of the National Comprehensive Cancer Network Volume 21 (2023): Issue 3.5 (Mar 2023): Abstracts from the NCCN 2023 Virtual Annual Conference
31 Mar 2023
Full access
HSR23-106: Real-World Study of Disease-Free Survival and Associated Patient Characteristics in Early-Stage Non–Small Cell Lung Cancer (NSCLC): A Retrospective Observational Study
Anne Shah, Jon Apple, Andrew J. Belli, Anna Barcellos, Eric Hansen, Laura L. Fernandes, and Ching-Kun Wang
In
Journal of the National Comprehensive Cancer Network Volume 21 (2023): Issue 3.5 (Mar 2023): Abstracts from the NCCN 2023 Virtual Annual Conference
31 Mar 2023
Items per page
10
20
50
Sort by
Article A - Z
Article Z - A
Author A - Z
Author Z - A
Date - Old to Recent
Date - Recent to Old
Page: ...
10
11
12
13
14
15
16
17
18
19
20
...
[3.235.40.122]
3.235.40.122
